What are the latest funding trends in nuclear fusion?

All funding deals in the nuclear fusion market over the last years

Below is the table listing all the deals. You can find our methodology at the end of this page.

If you want a deeper understanding of the market and its current dynamics, get our report covering the nuclear fusion market.

Is nuclear fusion funding really booming right now?

Nuclear fusion funding is genuinely much stronger today: more companies are raising, more deals are getting done, and the upper end of the market has become dramatically bigger.

We count 36 financings in the current comparable period, versus 21 one year earlier and 16 two years earlier. The number of funded companies increased from 20 to 27 year over year, while known capital rose from at least $2.15 billion to at least $3.81 billion.

Those three measures moving together are important. If the dollar total had surged while the number of funded companies stayed flat, we would mostly be looking at bigger checks for existing winners. Instead, the pool of companies receiving money expanded by 35% while capital increased by 78%.

The current capital figure is still conservative. Only 23 of 36 financings have a usable amount, compared with 20 of 21 a year earlier. Several Chinese rounds were disclosed only as broad RMB ranges or without a number, so the $3.81 billion represents known capital rather than everything that was actually raised.

Metric	Current YTD	Previous YTD	Two years prior	Current vs previous
Deals	36	21	16	+71.4%
Unique funded companies	27	20	15	+35.0%
Known capital	≥$3.813B	≥$2.148B	$411.5M	+77.6%
Median disclosed round	$100M	$18M	$21.7M	+455.6%
Average disclosed round	$165.8M	$107.4M	$31.7M	+54.4%
First financings	13	5	2	+160.0%
Companies raising more than once	6	1	1	+500%
Largest round	$1.00B	$863M	$100M	+15.9%

Is one giant fusion deal making the market look better than it really is?

No. Large fusion rounds are driving most of this year's dollar growth, but the money is spread across far more big financings than it was last year.

The largest current financing represents 26% of known capital. A year earlier, the largest deal represented 40%. The top three deals have also fallen from 71% to 51% of known funding, and the top five from 85% to 69%.

What changed is the depth of the large-round market. Fourteen financings now exceed $50 million, double the seven recorded in the previous comparable period. Ten are above $100 million, compared with five a year earlier and none two years earlier.

Commonwealth Fusion Systems' $1 billion round is obviously huge, but it sits alongside Helion's $500 million final Series G close, Proxima Fusion's €411 million financing, Focused Energy's $240 million Series A and several other nine-figure transactions. The boom survives the removal of any single company.

Would nuclear fusion funding still look strong without the big rounds?

Only up to a point. Once we remove fusion financings above $50 million, current funding is actually weaker than it was a year ago.

Capital from deals of $50 million or less totals about $166.6 million, down from $196.3 million in the previous comparable period. It is also below the $188 million recorded two years ago.

The picture changes when we use a $100 million cutoff. Funding excluding deals above $100 million reaches roughly $514 million, 61% above last year's $319 million. There has been a real improvement around the $50 million to $100 million layer, while smaller fundraising has not enjoyed the same lift.

So getting a modest fusion round has not obviously become easier. Companies that convince investors they can move toward large-scale engineering, though, are finding much deeper pools of capital.

Funding test	Current YTD	Previous YTD	Two years prior
Known capital	≥$3.813B	≥$2.148B	$411.5M
Capital excluding >$50M deals	$166.6M	$196.3M	$188.0M
Capital excluding >$100M deals	$514.0M	$319.3M	$411.5M
Deals above $50M	14	7	3
Deals above $100M	10	5	0
Top deal share	26.2%	40.2%	24.3%
Top three share	50.7%	71.2%	54.3%
Top five share	68.8%	85.1%	73.4%

Are more nuclear fusion startups actually getting funded now?

Yes. Nuclear fusion is currently producing a much larger crop of newly financed companies rather than simply recycling money among the same established names.

We identified 13 apparent first financings in the current period, up from five a year earlier and two two years earlier. Their share of all deals has climbed from 12.5% to 23.8% and now 36.1%.

The age data points in the same direction. The median company receiving financing is only about one year old today, compared with four years in the previous period. Young Chinese reactor developers account for much of that shift, while new businesses are also appearing around fusion controls, diagnostics and enabling systems.

Our first-financing classification cannot reconstruct every private financing in every company's history. It is based on the financing evidence we could establish publicly. Even with that caveat, a move from two apparent first financings to 13 is too large to dismiss as noise.

Are established fusion companies still getting most of the money?

Yes. Established fusion companies still absorb the overwhelming majority of disclosed capital, even while newcomers account for a growing share of deals.

Follow-on financings represent roughly $3.20 billion of current known funding, around 84% of the total. The median disclosed follow-on has reached $100 million, versus $18 million in the previous comparable period.

This creates a market with two active ends. Fresh teams are getting seed and first institutional checks, while companies that have already spent years de-risking their technology are raising hundreds of millions for manufacturing, demonstrators and commercial plants.

Helion shows how quickly that capital can arrive once investors buy into the commercialization story. It announced a $465 million Series G in June and later closed the oversubscribed round at $500 million. Proxima, founded only in 2023, has moved even faster: its €411 million financing now puts it among Europe's best-funded fusion companies.

Why are nuclear fusion rounds suddenly so much bigger?

Fusion rounds are much bigger now because several leading companies have moved from proving physics toward building machines, factories and power plants.

Commonwealth Fusion Systems said its latest $1 billion equity raise would support its commercial fusion program as SPARC assembly advances and the company develops its first ARC power plant. The company now says it has raised $4 billion in total.

The spending behind that ambition is increasingly tangible. In late September, CFS placed what it described as the largest single order for high-temperature superconducting tape, securing more than 10,000 kilometers from Fujikura for future ARC plants. That starts to explain why today's leading fusion companies need infrastructure-sized rounds.

Proxima's €411 million financing tells a similar story in Europe. The money is backing its Alpha net-energy demonstrator, expanded hiring and greater vertical integration. A few weeks later, the company described how the financing was already helping it secure materials early and avoid engineering delays. By September, Proxima had also signed an agreement with Lower Saxony around a large-scale fusion-grade HTS tape facility.

Focused Energy's $240 million round goes in the same direction. The company said the financing secured its construction phase, while investors included RWE, SPRIND and the European Innovation Council Fund. These are increasingly buildout rounds rather than conventional venture checks for laboratory research.

Does a $100 million fusion round feel normal now?

Among publicly disclosed fusion financings, nine-figure rounds have become surprisingly common.

More than half of the current deals with usable amounts are at least $100 million. A year ago the figure was one quarter. Two years ago, nine-figure financings were rare in the comparable sample.

We should still be careful with that $100 million median. Thirteen current deals do not have a sufficiently precise disclosed amount, and many of those are early rounds in China. If most are small, the true market-wide median would obviously sit below the median calculated from disclosed deals.

Even so, the number of confirmed nine-figure transactions leaves little doubt that the top end has changed. We no longer need one extraordinary round to produce a big funding year; there is now a group of fusion companies capable of raising on that scale.

Is fusion funding moving toward late-stage startups?

Surprisingly, no. Fusion deal activity is currently skewing younger even though the checks are getting larger.

Seed and Series A financings make up about two-thirds of current deals. The conventionally later Series B and Series D+ categories account for a much smaller share of transactions.

Series A has become especially unusual. Current Series A rounds represent about $1.21 billion of known capital and have a median of roughly $130 million. Focused Energy's $240 million Series A shows how misleading familiar software-style stage labels can become in fusion.

Eight current deals also have no stage we could establish confidently, and those transactions contain about 45% of known capital. So the lower recorded late-stage share does not mean mature fusion projects have suddenly stopped raising. Very young companies are appearing rapidly while some relatively early-labelled companies already need industrial-scale capital.

Which fusion technologies are investors paying more attention to now?

Tokamaks are winning the race for breadth today, while inertial fusion and stellarators are winning more of the race for large checks.

Tokamak companies represent about 31% of current deals, up from only 14% a year earlier. Their capital share, however, fell from roughly 51% to 39%. Investors are financing a wider Tokamak population rather than simply pushing more dollars into one dominant company.

Inertial fusion has gone the other way. Its deal share slipped slightly, yet its share of known capital jumped from about 4% to 19%. Focused Energy and Inertia account for much of that movement.

Stellarators are also becoming much more capital-intensive. Their deal share changed little, but their funding share rose by roughly nine percentage points, helped heavily by Proxima's €411 million round.

Alternative confinement had the opposite year. Its 2025 surge now looks increasingly temporary: the category fell from one-third of deals last year to about 8% currently.

Fusion approach	Current deal share	Current capital share	Deal-share change vs previous year	Capital-share change
Tokamak	30.6%	39.1%	+16.3 pp	-12.3 pp
Pulsed / magneto-inertial	19.4%	15.0%	+9.9 pp	-5.6 pp
Stellarator	16.7%	19.3%	-2.4 pp	+9.2 pp
Inertial	11.1%	19.0%	-3.2 pp	+15.2 pp
Alternative confinement	8.3%	7.4%	-25.0 pp	-5.7 pp
Fusion control & diagnostics	8.3%	0.2%	+8.3 pp	+0.2 pp
Magnet & power systems	5.6%	Undisclosed	+5.6 pp	-

Is inertial fusion becoming a serious funding rival to tokamaks?

Yes, at least for large financings. Inertial fusion currently attracts far more capital per deal than its share of fundraising activity would suggest.

Focused Energy's $240 million Series A is the clearest example. The company says the round is the largest fully secured Series A financing in fusion to date and is designed to fund construction through a fusion power plant. RWE participated alongside public and private investors.

Inertia's roughly $450 million milestone-linked financing adds another large transaction to a category with only four current deals in our dataset. Together, those financings explain why inertial fusion can account for just over one in ten deals but almost one-fifth of disclosed dollars.

Tokamaks remain the larger ecosystem by company count and total funding. The change lately is that inertial projects can now compete for the kind of checks previously associated mainly with the biggest magnetic-confinement companies.

Is China taking over the nuclear fusion startup market?

China is currently taking a commanding share of fusion deal formation, but North America still dominates the money.

Asia-Pacific accounts for roughly 69% of current financings, up from 48% a year earlier and 38% two years earlier. Most of that growth comes from the rapidly expanding Chinese private fusion ecosystem.

The dollar picture is almost inverted. Asia-Pacific represents about 27% of disclosed capital, while North America receives 54% despite producing only 19% of deals. Large CFS and Helion financings create much of that gap.

Chinese policy is also becoming more explicit. Shanghai's current industrial strategy names controlled nuclear fusion as a future industry and highlights high-temperature superconducting magnets, magnetic-confinement systems and other critical technologies. A separate Shanghai action plan calls for work on magneto-inertial fusion, laser fusion and high-temperature-superconducting Tokamak systems.

National policy is moving in the same direction, with fusion included among the future industries being developed during China's 2026–2030 planning period. We cannot attribute individual rounds to government policy, but the timing fits the sharp rise in new Chinese companies that we found.

Geography	Current deal share	Previous year	Two years prior	Current capital share
Asia-Pacific	69.4%	47.6%	37.5%	26.6%
North America	19.4%	23.8%	43.8%	53.9%
Europe	11.1%	28.6%	18.8%	19.5%
Asia-Pacific change vs previous year	+21.8 pp	-	-	-
North America change vs previous year	-4.4 pp	-	-	-
Europe change vs previous year	-17.5 pp	-	-	-
Current median disclosed Asia-Pacific round	$87.0M	-	-	-
Current median disclosed European round	$136.9M	-	-	-

Is Europe falling behind in fusion funding?

Europe is raising fewer fusion rounds right now, but the companies that do get funded are attracting very large checks.

Europe's share of deals dropped from about 29% to 11% year over year. Yet the median disclosed European round is roughly $137 million, higher than both North America and Asia-Pacific in our current sample.

Proxima and Focused Energy explain a lot of that result. Their €411 million and $240 million financings have given Europe two genuinely large private fusion companies pursuing very different technologies.

There is also fresh industrial infrastructure forming behind them. Proxima launched the Alpha Alliance with more than 30 industrial companies earlier this year and is now working on fusion-grade superconducting manufacturing. RWE invested €25 million directly in Proxima only months after agreeing to work with the company, Bavaria and the Max Planck Institute for Plasma Physics toward a commercial stellarator project at Gundremmingen.

Europe's current weakness is deal breadth, not an inability to finance a serious fusion company.

Are corporate investors losing interest in nuclear fusion?

Corporate and strategic investors are showing up in fewer fusion deals, but their involvement has become much more substantial when they do participate.

Only one quarter of current financings include strategic participation, versus roughly 62% a year earlier. Yet the median disclosed strategic deal has risen from about $16 million to nearly $87 million.

Recent examples look more commercial than exploratory. RWE invested in both Proxima and Focused Energy. Hyundai joined CFS's $1 billion round and said the companies would explore collaboration on future ARC power plants. CFS already has commercial relationships with Google and Eni, including power-purchase agreements connected to its planned first ARC plant.

CFS's latest supply-chain activity adds another dimension. Fujikura is expanding manufacturing capacity to support a contract for more than 10,000 kilometers of superconducting tape. Strategic involvement in fusion is increasingly moving toward power purchases, manufacturing capacity and plant development.

That is more interesting than simply counting how many corporations appear on cap tables.

Are the same investors controlling nuclear fusion funding?

No. The pool of disclosed fusion lead investors has expanded sharply this year.

We identified 38 unique current lead or co-lead investors, compared with 24 over the previous comparable period. Only CAS Star and CATL appear more than once as disclosed current leads or co-leads, with two deals each.

Lead information is available for about two-thirds of current transactions, so this is not a complete map of every syndicate. Still, there is little evidence of a tiny venture clique controlling the current funding wave.

The investor base now spans traditional venture funds, sovereign and government-backed investors, industrial companies, infrastructure-oriented capital and large institutional investors. CFS specifically highlighted pension funds, sovereign wealth funds and industrial partners when announcing its $1 billion round.

Strategic participation is less frequent overall, yet lead-investor breadth has increased. The private fusion capital pool itself looks deeper.

Are investors getting less picky about fusion startups?

No. Fusion investors appear more open to funding new teams today, but they remain very picky about which companies receive serious scale capital.

The clearest evidence is the gap between deal formation and smaller-round dollars. Many more young companies are receiving financing, yet capital in deals of $50 million or less has declined.

Large checks increasingly follow visible evidence of execution. Helion's latest financing arrived as Polaris hit new operating milestones and Orion moved into construction. Weeks after its round, Helion also secured Washington State licenses that it says are required for its planned fusion power plant.

CFS is assembling SPARC, has entered the PJM interconnection process for its first ARC plant and is now making industrial-scale supply commitments. Proxima is building Alpha and organizing suppliers around the project. Focused Energy explicitly tied its new capital to construction.

Investors are clearly willing to take more fusion bets. The bar for a $200 million, $500 million or $1 billion check is still in another league.

Why is private fusion money arriving so quickly now?

Private fusion money is arriving faster because commercialization plans are becoming concrete enough for investors to finance engineering milestones rather than distant scientific possibilities.

The U.S. Department of Energy's current fusion roadmap is built around that same transition. Its 2026 roadmap aligns public infrastructure and private-company timelines around a goal of commercial fusion in the mid-2030s, while the federal Milestone Program now works with eight private fusion companies on power-plant designs and critical technologies.

DOE's own budget material says four Milestone Program companies had collectively raised more than $386 million in private funding against $46 million of initially committed federal funding. That gives a useful example of public money being used to validate milestones rather than trying to finance entire private programs.

The UK is moving in a similar direction. Its 2026–2030 fusion strategy points to billions of dollars of private fusion investment globally and plans major public spending on facilities, supply chains and the STEP program. UKAEA also committed another £20 million this year to a seed fund that backs early-stage fusion and deep-tech companies.

Meanwhile, the companies attracting the biggest private rounds increasingly have specific machines, sites, suppliers, permits and prospective customers attached to their plans. Investors can still be wrong about when commercial fusion arrives. What they are financing today is far more concrete than a generic promise that fusion might eventually work.

Has nuclear fusion already become an industrial market rather than a science market?

Parts of nuclear fusion have clearly entered an industrial buildout phase, although the technology itself still carries major technical risk.

The freshest evidence comes from what companies are doing immediately after raising money. CFS is buying superconducting material in quantities measured in thousands of kilometers. Proxima is building an industrial alliance and planning manufacturing capacity around Alpha. Helion is expanding manufacturing while building Orion. Focused Energy says its latest financing covers construction.

Commercial contracts are appearing alongside that hardware. Eni has signed a power-purchase agreement worth more than $1 billion with CFS for output from its first ARC plant. CFS says Google has also agreed to buy power. Hyundai's recent investment is explicitly tied to exploring future ARC collaboration.

None of that guarantees fusion electricity will arrive on the schedules these companies advertise. It does show what kind of market investors are funding now: one increasingly built around construction, manufacturing, regulation, supply chains and future electricity sales.

What is actually changing in nuclear fusion funding?

Nuclear fusion funding is stronger today in two places at once: many more young companies are getting their first serious backing, while the best-funded projects have gained access to much larger pools of capital.

The biggest change is the upper end. Nine-figure financings are now common enough to form a real cohort, and the market is less dependent on one exceptional winner than it was last year. Smaller funding has not improved, though, which makes the current boom much more selective than the headline $3.81 billion total suggests.

Company formation is the second major shift. Fusion is currently attracting a new generation of startups, especially in China, and the median financed company has become much younger. Existing leaders still collect most of the dollars, but they no longer account for all of the growth in activity.

Technology preferences are moving too. Tokamaks are gaining breadth, inertial fusion is attracting much heavier checks, stellarators have moved into serious scale financing, and alternative confinement has lost much of last year's temporary deal advantage.

Geographically, China is becoming the center of new-company formation while North America remains the center of disclosed private capital. Europe's pipeline is thinner, but several European companies can now raise at genuinely global scale.

The strongest current trend is the combination of formation and buildout. Investors are simultaneously financing new technical approaches and putting hundreds of millions into companies preparing machines, factories and power plants. The apparent $100 million median round deserves more caution because current amount disclosure is incomplete. The broader shift is much harder to dispute.